Certified by Founder Lodge
Pheon Therapeutics
United Kingdom - London, England
START UP
1 Disclosed Funding Rounds $120,000,000
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Pheon Therapeutics is leveraging two decades of ADC experience to build a novel pipeline of next generation ADCs which offer the potential to treat solid tumors and liquid cancers that do not
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| May, 21 ,2024 | Series B | $120,000,000 |
Atlas Venture
Perceptive Advisors
Forbion
TCGX
Brandon Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
